Erasmus MC; Afdeling Longziekten

Rotterdam 3015 GD

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Idiopathic Pulmonary Fibrosis

Studies at this site

• A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) — Completed
• Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Completed